Kiel, Germany

Juergen Harder

This inventor holds 1 USPTO granted patent. Top assignee: Planton Gmbh. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juergen Harder. Retrieved from https://idiyas.com/inventor/juergen-harder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juergen Harder: Innovator in Antibiotic Proteins

Introduction

Juergen Harder is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of antibiotic research, particularly through his innovative work on human antibiotic proteins.

Latest Patents

Juergen Harder holds a patent related to human antibiotic proteins. This invention focuses on proteins, specifically SAP-2 and SAP-3, which exhibit antibiotic action. The patent also details a method for purifying certain antimicrobial proteins and outlines their use in antibiotic therapy, as well as the use of cells transfected with DNA coding for these proteins.

Career Highlights

Juergen Harder is associated with Planton GmbH, where he continues to advance his research in antibiotic proteins. His work has the potential to impact the medical field significantly, particularly in the development of new therapies for bacterial infections.

Collaborations

Some of his coworkers include Enno Christophers and Jens Schroeder, who contribute to the collaborative efforts at Planton GmbH.

Conclusion

Juergen Harder is a pioneering inventor whose work on antibiotic proteins is paving the way for new therapeutic options. His contributions are vital in the ongoing battle against antibiotic resistance.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…